Slide 1: Financial Results for FYE May 2025
Financial Results for FYE May 2025 July 17, 2025 The earnings forecasts in this document are based on the business environment as of the time of writing. Actual results may differ from projections due to a variety of factors. Note also that inquiries should be submitted in Japanese. Inquiries: Ozaki
Slide 2: FYE May 2025 Results / FYE May 2026 Plan
FYE May 2025 Results 1. Consolidated Financial Highlights 2. Consolidated Statement of Income 3. Consolidated Balance Sheet 4. Consolidated Statements of Cash Flows 5. Store Openings/Closings 6. Performance Highlights FYE May 2026 Plan 1. FYE May 2026 Plan (Consolidated) 2
Slide 3: FYE May 2025 Results
<= CREATESD I HOLDINGS 3
Slide 4: Consolidated Financial Highlights
1. Consolidated Financial Highlights Consolidated Results for FYE May 2025 Net sales Ordinary profit 457.0 billion yen 23.4 billion yen (108.2% YoY) (112.1% YoY) Ordinary profit margin: 5.1% Business Overview ◆ OTC: Continued promotion of everyday low price (EDLP) strategy led to strong performance
Slide 5: Consolidated Statement of Income for FYE May 2025
2. Consolidated Statement of Income for FYE May 2025 Net sales FYE May 2024 FYE May 2025 ・Continued promotion of EDLP strategy Results resulted in strong performance in sales Results and customer numbers at existing stores YoY Vs (Millions of yen) Share (Millions of yen) Share change plan ・In Q3, lo
Slide 6: Consolidated Balance Sheet for FYE May 2025
3. Consolidated Balance Sheet for FYE May 2025 May 31, 2024 May 31, 2025 Total assets Total assets (Millions of yen) 216,481 236,561 ■ Current assets +4,850 (+20,079) Increase in accounts receivable +2,080 Increase in merchandise +3,643 Current Total Decrease in cash and deposits –465 assets liabili
Slide 7: Consolidated Cash Flows for FYE May 2025
4. Consolidated Cash Flows for FYE May 2025 ■ Consolidated Statements of Cash Flows FYE May 2024 FYE May 2025 (Millions of yen) (Millions of yen) Change Net cash provided by operating activities 21,034 23,625 +2,590 Net cash used in investing activities –20,207 –20,700 –493 Net cash used in financin
Slide 8: Store Openings/Closings
5. Store Openings/Closings ■ Store openings/closings and renovations No. of store openings Kanagawa Tokyo Shizuoka Chiba Aichi Other Annual in FYE May 2025 Store Drug stores 17 6 2 6 5 4 40 opening Prescription drug stores 27 5 1 3 0 1 37 ・Store closings: 5 drug stores (2 scrap and build, 2 after co
Slide 9: Performance Highlights
6. Performance Highlights ■ YoY net sales comparison at all existing stores: 102.7% (H1: 102.3%; H2: 103.2%) └ OTC:101.8% Prescriptions:109.6% Emergency information on the （％） Nankai Trough earthquake Prevalence of acute leads to stockpiling and illnesses such as 9.5 10 subsequent drop in demand col
Slide 10: Performance Highlights: Net sales by segment
6. Performance Highlights ■ Net sales by segment FYE May 2024 FYE May 2025 Medical and health products Results Results OTC YoY Net sales Share Net sales Share ・Reactionary decline in sales of change (Millions of yen) (%) (Millions of yen) (%) (%) cold medicines, masks, and test kits following the ou
Slide 11: Performance Highlights: Prescription drug store department
6. Performance Highlights ■ Prescription drug store department FYE May 2024 FYE May 2025 YoY No. of prescriptions change Results Results ・Increased number of prescriptions filled from (%) promotion of in-store pharmacies Sales at all stores ・Reactionary decline following the increase in (millions of
Slide 12: Performance Highlights: Gross profit margin / SG&A ratio
6. Performance Highlights ■ Gross profit margin / SG&A ratio FYE May 2024 Results FYE May 2025 Results YoY Change Gross profit margin CSD Non- consolidated Result Share Result Share Change YoY ・Although the proportion of food (millions of yen) (%) (millions of yen) (%) (%) (%) sales increased, the h
Slide 13: FYE May 2026 Plan
FYE May 2026 Plan 13
Slide 14: FYE May 2026 Plan (Consolidated)
1. FYE May 2026 Plan (Consolidated) FYE May 2025 FYE May 2026 Plan Full-year Results YoY change YoY change (Millions of yen) Share (%) (Millions of yen) Share (%) (%) (Millions of yen) Net sales 457,093 100.0 491,500 100.0 107.5 +34,406 Gross profit 119,220 26.1 128,200 26.1 107.5 +8,979 SG&A expens